Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02360748 · ClinicalTrials.gov registry record · NA

A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients

A NA study of End Stage Renal Disease and Malnutrition, sponsored by Ochsner Health System.

Completed
Registry status
NA
Development phase
8
Enrollment target
2
Study locations

NCT02360748 is a NA study of End Stage Renal Disease and Malnutrition that has completed, run by Ochsner Health System. The registered enrollment target is 8 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02360748, a NA study of End Stage Renal Disease and Malnutrition, has completed, sponsored by Ochsner Health System.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
2
Study locations

Study Summary

The study proposes that addition of high protein plant based diet will improve serum albumin as well serum phosphate for patients with End Stage Renal Disease (ESRD) on Dialysis. Patient will be provided additional food items to help improve their nutritional status.

Interventions

  • DIETARY_SUPPLEMENT Plant based high protein food items

Study Locations (2)

Louisiana

  • OCHSNER - Baton Rouge
  • Davita - Baton Rouge

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2015-10
Est. Completion 2017-09-15
Phase NA

Sponsor

Ochsner Health System

29 total trials

What the Registry Record Tells You About NCT02360748

The ClinicalTrials.gov registry entry for NCT02360748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (99% lower). The listed sponsor is Ochsner Health System, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which Plant based high protein food items is the first listed.

NCT02360748 reports 2 study locations spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT02360748 about?

NCT02360748 is a clinical study titled "A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients". The study proposes that addition of high protein plant based diet will improve serum albumin as well serum phosphate for patients with End Stage Renal Disease (ESRD) on Dialysis. Patient will be provided additional food items to help improve their nutritional status.

What is the current status of trial NCT02360748?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-10. Estimated completion is 2017-09-15.

What conditions does trial NCT02360748 study?

This clinical trial studies the following conditions: End Stage Renal Disease, Malnutrition.

What interventions are being tested in trial NCT02360748?

The interventions under investigation include: Plant based high protein food items (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02360748?

This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02360748 being conducted?

This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.